Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Study of XL999 Administered Intravenously to Subjects With Metastatic Colorectal Cancer

NCT00277303 is registered in ClinicalTrials.gov with Symphony Evolution, Inc. as lead sponsor.

NCT NCT00277303
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00277303 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Study of XL999 Administered Intravenously to Subjects With Metastatic Colorectal Cancer
Lead sponsor
Symphony Evolution, Inc.
Phase
Phase 2
Overall status
Terminated
Start date
December 31, 2005
Completion date
February 28, 2007
Enrollment
17 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer